mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.03 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.03 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |